Please see Indication and Important Safety Information below in the pinned post.
Please see full Prescribing Information at https://pi.apellis.com/files/PI_SYFOVRE.pdf
This product information is intended for US Eyecare professionals only.
APELLIS®, SYFOVRE® and their respective logos are registered trademarks of Apellis Pharmaceuticals, Inc. ©2025 Apellis Pharmaceuticals, Inc 1/25 US-PEGGA-2300052 v3.0
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.SyfovreECP.com
Syfovre® (Pegcetacoplan Injection) Hcp Questions
Syfovre® (Pegcetacoplan Injection) Hcp's website is http://www.SyfovreECP.com
Syfovre® (Pegcetacoplan Injection) Hcp's LinkedIn profile is https://www.linkedin.com/company/syfovrehcp
Syfovre® (Pegcetacoplan Injection) Hcp's industry is
Pharmaceutical Manufacturing
Syfovre® (Pegcetacoplan Injection) Hcp's top competitors are
Eylea Hd® (Aflibercept) Injection Hcp,
Alnylam Pharmaceuticals,
Keytruda® (Pembrolizumab) Hcp,
Regeneron,
Apellis Pharmaceuticals,
Bristol Myers Squibb,
Amgen,
Abbvie,
Vabysmoⓡ (Faricimab-Svoa),
Coopervision.
Syfovre® (Pegcetacoplan Injection) Hcp's categories are Pharmaceutical Manufacturing
